Table 3.
Inflammatory markers
| Marker (units) | No history of cancer (n) mean | Cancer survival (n) mean | Active oncologic treatment (n) mean | p value |
|---|---|---|---|---|
| Ferritin, ng/mL | (780) 1,337 | (53) 986 | (25) 2,002 | ns |
| LDH, U/L | (2,107) 350 | (136) 337 | (68) 498 | 0.01 |
| Procalcitonin, ng/mL | (885) 0.99 | (48) 1.2 | (35) 1.2 | ns |
| C-reactive protein, mg/L | (2,168) 105.9 | (140) 97.49 | (68) 110.46 | ns |
| D-dimer, ng/mL | (1,250) 2,531.8 | (79) 2,746.7 | (40) 1,680.1 | ns |
| Lymphocytes, 103/µL | (2,255) 1,235 | (149) 1,101 | (71) 1,000 | ns |
| Neutrophils, 103/µL | (2,256) 6,181 | (149) 5,692 | (71) 5,097 | ns |
| IL-6, pg/mL | (754) 133.2 | (39) 117.2 | (14) 45.6 | ns |
| IL-12, pg/mL | (728) 0.48 | (38) 0.73 | (14) 0.53 | ns |
| IL-10, pg/mL | (744) 7.2 | (39) 5.1 | (14) 10.2 | ns |
| IL-17, pg/mL | (479) 1.3 | (25) 0.82 | (9) 0.69 | ns |
| IL-1B, pg/mL | (416) 0.45 | (15) 0.26 | (12) 0.53 | ns |
| IL-8, pg/mL | (745) 37.6 | (36) 37.74 | (14) 25 | ns |
| TNF, pg/mL | (610) 6.8 | (30) 7 | (14) 8.3 | ns |
| INFg, pg/mL | (478) 4.1 | (25) 1.7 | (9) 8.1 | ns |
LDH, lactate dehydrogenase; IL, interleukin; TNF, tumor necrosis factor; INFg, interferon gamma.